Department of Medicine 3 – Rheumatology and Immunology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Update on imaging in gout: contrasting and comparing the role of dual-energy computed tomography to traditional diagnostic and monitoring techniques (2018) Bayat S, Baraf HSB, Rech J Journal article MICRORNA-125B REGULATES APOPTOSIS IN SYSTEMIC SCLEROSIS (2018) Kozlova A, Pachera E, Maurer B, Juengel A, Distler J, Kania G, Distler O Conference contribution RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK (2018) Elhai M, Distler O, Smith V, Matucci-Cerinic M, Alegre-Sancho JJ, Truchetet ME, Braun-Moscovici Y, et al. Conference contribution NEW SYSTEMIC SCLEROSIS RISK LOCI IDENTIFIED THROUGH A META-GWAS STRATEGY (2018) Lopez-Isac E, Acosta-Herrera M, Assassi S, Simeon CP, Carreira PE, Castellvi I, Ortego-Centeno N, et al. Conference contribution Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study (2018) Jaeger VK, Siegert E, Hachulla E, Airo P, Valentini G, Matucci-Cerinic M, Scorza R, et al. Conference contribution Orphan Nuclear Receptor Ror alpha Is a Key Regulator of Tgf beta- and WNT-Signaling in Fibrotic Diseases (2018) Kagwiria R, Liang R, Matei AE, Sihler N, Chen CW, Burris T, Distler O, et al. Conference contribution Only a Minor Proportion of Individuals with Anti-Aminoacyl-tRNA Synthetase Autoimmunity Presents with the Clinical Picture of "Antisynthetase-Syndrome" (2018) Knitza J, Schenker H, Schett G, Distler J Conference contribution Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease (2018) Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al. Journal article LOOSING DAS28-ESR, BUT STAYING IN BOOLEAN REMISSION-IS IT POSSIBLE? DATA FROM THE PROSPECTIVE, RANDOMISED RETRO TRIAL ON RHEUMATOID ARTHRITIS PATIENTS IN STABLE REMISSION (2018) Erhard J, Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, et al. Conference contribution LONG NONCODING RNA H19X IS A MASTER REGULATOR OF EXTRACELLULAR MATRIX PRODUCTION IN SYSTEMIC SCLEROSIS (2018) Pachera E, Assassi S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution